FDA Drug Application (018927) for TEGRETOL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number018927
Product Number001
FormSUSPENSION;ORAL
Dosage100MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTEGRETOL
Active IngredientCARBAMAZEPINE

Active IngredientCount
List of drugs with Active Ingredient CARBAMAZEPINE8


Back to FDA Applications sponsored by NOVARTIS